Quick Links
In The News
HONEYWELL HOMMED WINS 2008 MEDICAL DESIGN EXCELLENCE AWARD
Brookfield, Wis., April 7, 2008 – Honeywell (NYSE: HON) today won the 2008 Medical Design Excellence Awards (MDEA) for its GenesisTM DM remote patient care device. The Genesis DM won in the rehabilitation and assistive-technology products category.
Full Article >>
Integration of Systems Improves Healthcare Providers Telehealth Connectivity
Integration of Systems Improves Healthcare Providers Telehealth Connectivity
Brookfield, Wis. – Dec. 11, 2007 – Honeywell (NYSE: HON) HomMed today announced
that it will partner with Procura, LLC, a leading global provider of information systems and services for healthcare entities, to help healthcare providers advance how they digitally store patient records and improve healthcare solutions.
Full Article >>
HONEYWELL HOMMED LAUNCHES NEW TELEHEALTH ECOSYSTEM
LifeStream™ Platform and Genesis™ DM
Enhances Patient Outcomes and Care Delivery
BROOKFIELD, Wis., Oct. 3, 2007 – Honeywell (NYSE: HON) today introduced its Telehealth Ecosystem, a comprehensive telehealth solution designed to optimize patient and financial outcomes by providing a platform for improving the standardization and quality of care.
Full Article >>
HONEYWELL HOMMED WINS 2008 MEDICAL DESIGN EXCELLENCE AWARD
Innovative Device Recognized for Design Excellence
and Patient Ease-of-Use
The award-winning
Honeywell HomMed remote patient monitoring device is ideal for both the patient
and the medical professional, using text or voice prompts to guide patients
through a series of yes/no questions that allow medical professionals to
monitor and receive a thorough health assessment.
The
Honeywell HomMed remote patient monitoring device is part of the LifeStream
Ecosystem and provides patients with an easy-to-use device for the home. The
three-part LifeStream ecosystem, providing cost-effective
care for patients at home, includes the patient-facing Genesis DM device,
software applications and service. Patients suffering from a variety of chronic
conditions, such as congestive heart failure, chronic obstructive pulmonary
disease, coronary artery disease, diabetes and hypertension, can use the Genesis
DM device to assess their condition in the privacy of their homes. This
information is transmitted securely over the internet to their caregiver for
monitoring and the appropriate intervention if necessary.
“When
designing the Genesis DM, we listened to the ultimate customer – patients.
Without more consistent patient use of telemonitoring, the delivery of
telehealth cannot be optimized,” said Mike Benjamin, president of Honeywell
HomMed. “We’re honored to receive this recognition and proud of the team at
Honeywell HomMed who made this possible. Our focus continues to be ensuring
chronically ill patient’s independent living with dignity for at an affordable
cost.”
“It is
very important to us to provide our patients and caregivers with the most
meaningful information with regards to patient health,” said Terry
Duesterhoeft, vice president of Marketing & Sales, Honeywell. “As we
developed the Genesis DM, we closely evaluated the entire patient environment
and discovered that the integration of all data (both objective and subjective)
truly differentiated this product in the overall telehealth ecosystem.”
The Medical
Design Excellence Awards, now in its eleventh year, recognizes companies and
individuals worldwide involved in the design, engineering, manufacture or
distribution of finished medical devices or medical packaging. Entries are
evaluated by a multidisciplinary panel of jurors with expertise in engineering,
medicine, industrial design, manufacturing and other design- and
healthcare-related fields.
For more
information about Honeywell HomMed’s telehealth solutions, visit www.hommed.com.
Contact:
Herly Karlen
262-252-5847
About
Honeywell
Honeywell International is a $36 billion
diversified technology and manufacturing leader, serving customers worldwide
with aerospace products and services; control technologies for buildings, homes
and industry; automotive products; turbochargers; and specialty materials. Based
in
Forward Looking Statement
This
release contains “forward-looking statements” within the meaning of Section 21E
of the Securities Exchange Act of 1934. All statements, other than statements
of fact, that address activities, events or developments that we or our
management intend, expect, project, believe or anticipate will or may occur in
the future are forward-looking statements. Forward-looking statements are based
on management’s assumptions and assessments in light of past experience and
trends, current conditions, expected future developments and other relevant
factors. They are not guarantees of future performance, and actual results,
developments and business decisions may differ from those envisaged by our
forward-looking statements. Our forward-looking statements are also subject to
risks and uncertainties, which can affect our performance in both the near- and
long-term. We identify the principal risks and uncertainties that affect our
performance in our Form 10-K and other filings with the Securities and Exchange
Commission.